Those western vaccines could be cheaper because their government has subsidised billions of fund and so far those vaccines can’t get approval as yet.
It seems that those vaccines will be facing difficulties in distribution because the vaccine needs ultra low temperature for storage and distribution. When you include those costs, it’ll be much more expensive than Chinese vaccines.
More importantly, so far no negative reports on the Sinopharm vaccines while the western ones are on hold now.
Western vaccines won't reach asia. Selfish American white man already book all of capacity from western country. Even their running dog Taiwan too have to join Covac WHO for vaccines.
There are more than 150 coronavirus vaccine development across the world. The World Health Organization is also coordinating to develop the vaccines.
Here are the candidates that have reached phase three :
Jonhson & Johson ( USA) Moderna Therapeutics ( USA) Pfizer/BioNTech ( USA& Germany) University of Oxford/Astra Zenca (UK) Sinovac/Butantan ( China/Brazil) Sinopharm ( China) Murdoch Children Research Inst(Australia) CanSino Biologics (China) Gamaleya- Sputnik V ( Rusia)
Out of these only Univ of oxford /AstraZenca vaccine has remained on hold in USA only due minor side effects. But the trials are still resume in UK, Brazil and South Africa.
Even after a vaccines are approved, the potential major issues are production and distribution and of course at what cost .
Kens88, you should buy back Titijaya when it’s still cheap. Now operator is pressing down price to flush out those weak and short term holders.
Go and read their announcements again. It’s not just building a warehouse so simple la. You don’t have to partner with Sinopharm to build a warehouse. Over the years, Titijaya has strong track record working with other China state owned companies for instance CREC.
Titijaya being the partner of Sinopharm will sure want to distribute the vaccines once approved.
Aiyo ..talk what vaccine in Msia lah...population 30mil plus..how much can earn from the vaccine lah..alot kah...lol..unless you are Asean Sole distributor with 500mil population lah...lol...aiyoyo...kikiki
With Kanger’s announcement, Titijaya will be forced to announce their plan sooner.
Anyway, Titijaya has agreement with Sinopharm to distribute to 5 countries with over 400 million population. Kanger is just probably just a distributor getting the vaccine from Titijaya production hub in Malaysia.
Show me where got titi signed the agreement for vaccine? The only thing titi signed was medical device and not even vaccine word found in the agreement. Sino not about vaccine alone
TTJY should include vaccine whether it is done yet or not, unless there is something like the requirement of procedure or law that they hinder them from doing so. Dont need to get excited or frustrated when Kanger get it, the present price only reflects the distribution of Medical products and trade of gloves with Sinopharm. Wait for finalization dont need to fight each other.
Actually collaboration (not limited to Malaysia market) on covid's test kids, hand glove, PPE and medical products had give positive impacts to Titijaya, vaccine is extra bonus if included.
China companies group itself are numbers... Naming those already in news
National Biotech Group Company (CNBG) Sinopharm Group Hunan Changde Medical Co Ltd Sinopharm Medical Equipment QuanZhou Co. Ltd Sinopharm China National Medical Device Company China National Pharmaceutical Group Corp
Malaysia companies group also many..No need to name any . Everyone already know from Pharma company to construction, to engineering , seem like everyone want to give out some news , reason only known to themselves . Will Vaccine a good biz? or can it be consider a biz at a very first place ?
Prospect is not on vaccine. It should be on medical trading and distribution of medical and hospital equipment, as well as medical industry-related real estate and rubber glove trading .
Divert to Medical product with Sinopharm, with or without vaccine, it is still profitable as covid 19 not going to disappear soon. Just look at LKL up from 8.5 cts to 98 cts now. The business only start in Nov after EGM, so will not reflect in QR.
It’s quite obvious the operator is trying to push down prices ahead of the big announcement which will be out soon. We happily wait and eat and lower prices. Best time to buy is when low and not chasing the rally.
Titijaya property business NTA is 0.86 and now with the new business diversification profit is expected to rise further and even without vaccine play, current price is already a good bargain
Buy Titijaya now is low downside risk with huge upside potential.
Joe, if you want sure make money please place your money in FD which will guarantee return around 2%pa. haha
You have to believe in Tan Sri Lim capabilities in bringing profits to his business
Whereas for Vaccine with Sinopharm, please go and read their agreement again. Clear hints can be found. Vaccines wording can’t be found in the agreement because no vaccines are approved now. You can’t stipulate something which is not approved in a formal agreement.
Anyway, more details will be out by Nov, as stated in the agreement.
what happen after you sold at 40 cts but have to buy back at 50 cts, having agreement to sell gloves to Sinopharm and distribute their medical products is already very good without vaccines.
Selling gloves make more money or selling vaccines ? Will selling vaccines able to make money at the current situation. Or Should any organization make money from vaccines ?? Vaccines must first be given to all without taking profit into consideration. Many research are also sponsored . It should be non profit at this stage . It is about saving life.
For titijaya, if want to be safe , then wait for next QR. They are trading rubber gloves thru Rubberex. Should reflex some income from there . Titijaya not like many other they talking about set up glove factory and etc . So far , i see Titijaya are realistics on this path. They are still doing what they are doing before the pandemic but just have an subsidiary company to diversified into medical related line . Which, if success, then great, it not , they are still who they are , biz are just affect by the market like everyone out there due to the pandemic.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Friendship
1,616 posts
Posted by Friendship > 2020-09-28 15:32 | Report Abuse
Those western vaccines could be cheaper because their government has subsidised billions of fund and so far those vaccines can’t get approval as yet.
It seems that those vaccines will be facing difficulties in distribution because the vaccine needs ultra low temperature for storage and distribution. When you include those costs, it’ll be much more expensive than Chinese vaccines.
More importantly, so far no negative reports on the Sinopharm vaccines while the western ones are on hold now.
So, it again shows Chinese vaccines are better.